PMID: 7516254Feb 1, 1994Paper

Involvement of neurokinins in the non-cholinergic response to activation of 5-HT3 and 5-HT4 receptors in guinea-pig ileum

British Journal of Pharmacology
M J RamírezB Lasheras

Abstract

1. The involvement of neurokinins in the non-cholinergically-mediated contractile response induced by stimulation of 5-HT3 and 5-HT4 receptors has been examined in the longitudinal muscle-myenteric plexus preparation of the guinea-pig ileum. 2. The 5-HT3 receptor agonist, 2-methyl-5-hydroxytryptamine (2-methyl-5-HT), showed a lower potency in this preparation than the more selective 5-HT4 receptor agonist 5-methoxytryptamine. The effect of both drugs was markedly reduced by atropine. 3. Substance P (SP) and neurokinin B (NKB) produced biphasic concentration-response curves in the preparation. Neurokinin A (NKA), the NK1 receptor agonist, [Sar9,Met(O2)11]SP and the NK3 receptor agonist, senktide yielded monophasic concentration-response curves. 4. After desensitization of the NK1 receptor with SP or [Sar9,met(O2)11]SP, in the presence of atropine, the contractile response to 2-methyl-5-HT was entirely blocked. Desensitization of NK3 receptors with NKB, also in the presence of atropine, fully suppressed the 5-HT4 receptor-mediated contraction evoked by 5-methoxytryptamine. 5. In preparations prelabelled with [3H]-choline, SP produced a concentration-dependent increase in tritium overflow, an index of [3H]-acetylcholine release, w...Continue Reading

References

Feb 1, 1976·Canadian Journal of Physiology and Pharmacology·J C Szerb
Feb 1, 1992·Trends in Neurosciences·J B FurnessS Pompolo
Feb 25, 1992·European Journal of Pharmacology·A L Meulemans, J A Schuurkes
Mar 1, 1991·Neuropharmacology·A Töröcsik, E S Vizi
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R LauferZ Selinger
Nov 24, 1986·Life Sciences·H I JacobyJ L Vaught
Oct 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·H KilbingerP Holzer
Jan 12, 1987·Life Sciences·D RegoliP D'Orléans-Juste
Jul 1, 1986·Journal of Medicinal Chemistry·R LauferZ Selinger
Jul 1, 1987·Neuropeptides·G DrapeauD Regoli
Dec 1, 1987·Neuropharmacology·M T Molinero, J Del Rio
Jan 10, 1989·European Journal of Pharmacology·G J Sanger, D R Nelson
Oct 1, 1989·Trends in Pharmacological Sciences·D E ClarkeJ R Fozard
Jun 1, 1988·British Journal of Pharmacology·A ButlerM B Tyers
Mar 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·C M LeeB E Sandberg
Feb 1, 1984·The Journal of Physiology·D E Clapham, E Neher
Mar 1, 1993·Trends in Pharmacological Sciences·K J Watling, J E Krause
Sep 1, 1957·British Journal of Pharmacology and Chemotherapy·J H GADDUM, Z P PICARELLI
Jan 1, 1991·Neurochemistry International·S Guard, S P Watson

❮ Previous
Next ❯

Citations

Dec 19, 1996·European Journal of Pharmacology·M Yamano, K Miyata
May 30, 1997·European Journal of Pharmacology·Y NagakuraK Miyata
Jan 7, 1999·European Journal of Pharmacology·M MinamiK Kisara
Jan 1, 1997·Pharmacology & Therapeutics·P Holzer, U Holzer-Petsche
Jan 1, 1997·Pharmacology & Therapeutics·P Holzer, U Holzer-Petsche
Sep 16, 2000·International Journal of Immunopharmacology·J SevcíkK Masek
Nov 20, 1997·Comparative Biochemistry and Physiology. Part A, Physiology·M B Hansen, E Skadhauge
Sep 1, 1994·British Journal of Pharmacology·M J RamírezB Lasheras
Oct 13, 2009·European Journal of Pharmacology·Katharina HeimesEugen J Verspohl
Jun 28, 2008·Neuropeptides·Frankie H M ChengJohn A Rudd
Aug 18, 2009·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Viktoria DénesRobert Gábriel
Jun 14, 2006·British Journal of Pharmacology·Navinisha ChettyIan M Coupar
May 2, 2016·Neuroscience and Biobehavioral Reviews·Caroline Sévoz-Couche, Charly Brouillard
Mar 21, 2002·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·F De PontiG M Frigo
Aug 7, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Masaru MinamiMasahiko Hirafuji
Jul 23, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Mintsai LiuMichael D Gershon
Oct 21, 1999·The Journal of Pharmacy and Pharmacology·J GoldhillN Selve
Jul 1, 1996·Pharmacology & Toxicology·V Csillik-PerczelL G Harsing
Jun 28, 2020·European Journal of Pharmacology·Tiina LeinoUllamari Pesonen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.